MiMedx Group (NASDAQ: MDXG) reported Q4 EPS of $0.07, $0.01 better than the analyst estimate of $0.06. Revenue for the quarter came in at $92.9 million versus the consensus estimate of $89.4 million.

For earnings history and earnings-related data on MiMedx Group (MDXG) click here.